#Canada #Toronto #Medical Devices #health data #iGan Partners

iGan Partners Portfolio Update

On September 11, 2026, iGan Partners, a venture capital firm based in Toronto, provided an update on its portfolio, showcasing impressive advancements made by its invested companies in the medical technology and health data sectors. This recent announcement highlights the firm’s commitment to supporting innovative solutions that improve healthcare delivery and outcomes.

Key Milestones from the Portfolio

Flosonics Medical has made headlines by securing a development contract worth up to $70 million with the Biomedical Advanced Research and Development Authority (BARDA). This contract includes an initial funding sum of $15 million and revolves around the enhancement of their FDA-cleared FloPatch device. Flosonics is advancing its real-time ultrasound technology, which is beneficial in trauma care and mass casualty situations, showcasing an innovative use of AI in medical devices.

Exact Imaging has demonstrated robust growth with a 166% increase in revenue year-over-year during its inaugural year after a strategic shift from a singular international distribution model to a more expansive direct sales approach. To strengthen its market presence, Exact Imaging has also bolstered its North American sales team, and their peer-reviewed research supporting the ExactVu device has now surpassed 140 published studies.

MolecuLight, in collaboration with The Royal Orthopaedic Hospital NHS Foundation Trust, has published significant clinical findings from a pilot study. This research evaluated the efficacy of fluorescence imaging during orthopedic surgeries, thereby extending its clinical evidence base beyond just chronic wound care applications. This study represents an important step for MolecuLight as they integrate their technology into surgical processes.

In another important partnership, Cosm Medical has teamed up with Duke Health and Mayo Clinic to develop and market Gynethotics Recovery, a brand new class of personalized recovery devices designed for patients post-pelvic reconstructive surgery. This collaboration utilizes Cosm's cutting-edge digital gynecology platform, which integrates medical imaging and 3D printing technology, indicating a forward-thinking approach to patient recovery.

Adding to the innovation landscape, Marble has rolled out a dedicated medical records service specifically for those eligible under the Pan-Canadian Claimants' Compensation Plan. This initiative aims to streamline the collection of medical evidence for claimants associated with the $2.521 billion fund stemming from Canada’s tobacco settlement.

Lastly, Segmed contributed its data expertise to a research paper authored with Stanford University and the University of Washington School of Medicine, which was published in The International Journal of Cardiovascular Imaging. This study investigated various large language model configurations on cardiac imaging reports, revealing that open-weight models can achieve accurate results comparable to expert radiologists.

Conclusion

The recent developments across iGan Partners' portfolio signify a strong momentum in medical technology and health data sectors. These advancements not only enhance patient care but also showcase how innovation in healthcare is evolving through partnerships and the integration of technology. iGan Partners continues to champion companies that prioritize effective, technology-driven solutions essential for the advancement of medical care.

iGan Partners remains focused on supporting visionary companies, further reinforcing its commitment to shaping the future of health technology.